Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
How Near-Death Cells Seed Metastatic States
2026-08-19
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving impending cell death can acquire stable prometastatic states called PAMEs. Their work links ER stress, PERK–CHOP signaling, nuclear reprogramming, stemness, and cytokine-mediated recruitment of neighboring PIM cells to the origin of metastases.
-
PD 173074 for FGFR1 and LUAD Assays
2026-08-19
PD 173074 provides a practical pharmacological probe for testing FGFR1 dependence, VEGFR2-linked angiogenesis, and drug-response phenotypes in lung adenocarcinoma models. This workflow combines CENPO-guided patient biology with target-engagement assays, dose design, and troubleshooting strategies that distinguish pathway suppression from nonspecific toxicity.
-
Anlotinib for IADSRCT: Case and Literature Review
2026-08-18
This case report describes the first reported clinical use of anlotinib in metastatic intra-abdominal desmoplastic small round cell tumor, with radiographic lymph-node reduction and tolerable toxicity after prior surgery and chemotherapy. Its main significance is hypothesis-generating: it connects the anti-angiogenic, multi-target activity of anlotinib with a rare tumor lacking standardized systemic treatment, while also highlighting the limits of single-patient evidence.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-08-18
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and membrane-integrity assessment. It is suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, but it should not be treated as a general live-cell nuclear stain.
-
Imaging the MAVS Checkpoint with Cy5 Detection
2026-08-17
ASB3-mediated degradation of MAVS reveals a critical antiviral control point. This thought-leadership guide shows how Cy5 fluorescence workflows can translate that mechanism into more rigorous, spatially resolved evidence while defining the limits of secondary-antibody detection.
-
Adamtsl3, MMP9, and Perineuronal Net Plasticity
2026-08-17
The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal net integrity in parvalbumin-positive interneurons and links its loss to elevated MMP9 activity, reduced Otx2 uptake, oxidative stress, and renewed adult cortical plasticity. Its genetic, morphological, biochemical, and pharmacological evidence provides a mechanistic framework for studying extracellular-matrix regulation in schizophrenia-related neurobiology.
-
AEBSF.HCl: A Mechanistic Assay Guide
2026-08-16
AEBSF.HCl is more than a broad-spectrum serine protease inhibitor: it can help distinguish extracellular or serine-protease effects from cathepsin-driven necroptosis. This guide integrates AEBSF.HCl chemistry with lysosomal membrane permeabilization findings to improve assay interpretation.
-
Saracatinib (AZD0530) Assay Workflows
2026-08-15
Build mechanism-led cancer assays around Saracatinib (AZD0530), from Src pathway confirmation to proliferation, migration, and xenograft readouts. The workflow also shows how findings on Reelin–SFK signaling can sharpen experimental controls without overstating cross-domain evidence.
-
Plant Autophagy: The VPS41-to-VAPV Pathway
2026-08-14
Jiang and colleagues identify a plant-specific condensates-to-VPS41-associated phagic vacuoles conversion pathway that transports autophagosomes toward the vacuole for degradation. Their findings position VPS41 dynamics, ARLA1 GTPases, and SNARE coupling as central regulators of plant autophagic flux, largely outside the canonical RAB7 route.
-
BRD4, TXNIP, and Ferroptosis Sensitivity
2026-08-14
The reference study identifies TXNIP as a key mediator of JQ1 responses in solid cancer cells, linking BRD4 inhibition to reduced histone H4 UFMylation, altered c-MYC chromatin binding, and cell-cycle dormancy. Its findings provide a mechanistic rationale for combining a BET bromodomain inhibitor with ferroptosis-inducing strategies while also clarifying important limits for interpretation and translation.
-
Romidepsin: Assay Design for HDAC2–SmD2
2026-08-13
Romidepsin (FK228) is more than a cytotoxic HDAC probe: it can help dissect the HDAC2–SmD2–DNA repair axis in hepatocellular carcinoma. This article translates recent spliceosome findings into a practical framework for mechanistic assays and combination studies.
-
Anlotinib hydrochloride for Angiogenesis Assays
2026-08-13
Anlotinib hydrochloride provides a practical way to connect VEGFR2, PDGFRβ, and FGFR1 blockade with endothelial migration, tube formation, and ERK readouts. This workflow-focused guide helps researchers build reproducible anti-angiogenic experiments while avoiding common interpretation and dosing errors.
-
Pazopanib Hydrochloride Assay Workflow
2026-08-12
Build more informative Pazopanib Hydrochloride experiments by separating growth arrest from cell death and by pairing tumor-cell, endothelial, and three-dimensional models. This workflow turns GW786034 dose responses into mechanism-aware data for renal cell carcinoma and soft tissue sarcoma research.
-
CCR5-Positive EVs in Rheumatoid Arthritis
2026-08-12
The reference study identifies CCR5-bearing extracellular vesicles from rheumatoid arthritis synovial fibroblasts as active mediators of cartilage destruction, bone erosion, and NF-κB signaling. By combining CCR5-deficient vesicles with Maraviroc-loaded vesicles in cell and adjuvant-induced arthritis models, the work provides a mechanistic framework for testing EV-associated CCR5 as a therapeutic target.
-
Phosbind Acrylamide: From Biology to Gel
2026-08-11
Phosbind Acrylamide translates protein phosphorylation into an interpretable SDS-PAGE mobility shift without phospho-specific antibodies. This article connects the reagent’s assay logic to the lncRNA–kinase–phosphatase mechanism reported in pigeon pea pollen tube biology and outlines a disciplined validation workflow.